Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
04/2008
04/22/2008US7362223 Chemical, biological, radiological, and nuclear weapon detection system with environmental acuity
04/22/2008US7362110 Measurement cell for liquids
04/22/2008US7361821 Using oligonucleotide probes for detection, identification and/or sequencing of nucleic acids and/or biomolecules; for use in medical diagnostics, forensics, toxicology, pathology, biological warfare
04/22/2008US7361746 Methods and compositions for detection of Mycobacterium avium complex species
04/22/2008US7361735 Comprises nucleotide sequences coding lipopolysaccharide induced tumor necrosis factor - alpha factor (LITAF) proteins for use in treatment and prevention of cell proliferative disorders; antitumor agents; immunotherapy
04/22/2008US7361733 Stimulation, expansion of lymphocytes; polynucleotides; genetic engineering
04/22/2008US7361635 Simultaneous modulation of multiple genes
04/22/2008US7361633 Treating sex-hormone dependent tumors and cancer such as benign prostate hyperplasia and uterine fibroids with the decapeptide: Ac-D-Nal(2)-D-4-ClPhe-D-Pal-Ser-1 MePal-D-IsopropylLys-Leu-lsopropylLys-Pro-D-AlaNH2
04/22/2008US7361517 Diagnosis and/or monitoring of patients with systemic lupus erythematosus by isolating reticulocytes from a blood sample, determining the level of a C4d complement pathway component on the reticulocytes, and comparing it to a control level; an elevated lovel indicates an acute inflammatory episode
04/22/2008US7361516 Field of modular multifunctional ligands
04/22/2008US7361515 Using immobilzed acceptors and fluorescent dyes to monitor biopolymers in fluid sample; medical diagnostics
04/22/2008US7361514 Apparatus for detection of volatile organic compounds in air: artificial olfaction and air pollution
04/22/2008US7361513 Cellular controls for glycated hemoglobin Hb A1c
04/22/2008US7361512 Low hemoglobin concentration cell percentage and method of use in detection of iron deficiency
04/22/2008US7361511 Comparing gene expression levels in normal and tumor cells, diagnosis, treating with an antisense oligonucleotide, and monitoring results
04/22/2008US7361510 Methods of detection of iron deficiency
04/22/2008US7361507 Replacing the amino acid in the nitrilase with a cysteine, wherein nitrilase selectivity of the nitrilase NitA of Comamonas testosteroni is modulated
04/22/2008US7361505 Multipotent neural stem cell compositions
04/22/2008US7361502 Nucleic acid molecule encoding a neuronal serine-threonine protein kinase
04/22/2008US7361500 Apparatus and method for electrically contacting biological cells suspended in a liquid
04/22/2008US7361498 Transgenic yeast comprising g-protein coupled orphan receptors for use as tools in identifying ion channel modulators
04/22/2008US7361489 Nucleic acid amplification methods
04/22/2008US7361488 Monitoring adjustment in transcription products during gene amplification
04/22/2008US7361485 Method for the detection of proteolytic enzymes
04/22/2008US7361484 Truncated glycogen synthase kinase 3 crystallizable polypeptide; drug screening for Alzheimer's Disease treatments, antidiabetic and antiinflammatory agents; exposing a GSK3- beta molecule to a putative inhibitor, and measuring the specific enzymatic activity of said GSK3- beta molecule
04/22/2008US7361482 Using labeled c theta complex in permeabilized cells to detect and monitor cholesterol accumulation; diagnosing neurodegenerative diseases; drug screening
04/22/2008US7361481 Diagnosing or monitoring a lysosomal storage disease in a patient by measuring the level of at least one saposin in a tissue sample, the level providing an indication of the presence or absence or extent of the disorder in the patient
04/22/2008US7361480 Method and means for detecting gluten-induced diseases
04/22/2008US7361479 Determining the presence or amount of newly synthesized antibody in a sample in response to an immunogen by detecting the released antibodies or parts thereof in a sample containing lymphocytes which have been disrupted whereby to release the synthesized antibodies
04/22/2008US7361478 Disposing cell comprising sodium channel blocker into a well, disposing fluorescent dye into well; adding sodium channel blocker, to be identified, into well; passing stimulating current to generate an action potential; optically measuring
04/22/2008US7361477 Methods and compositions for inhibiting cellulolytic symbionts
04/22/2008US7361476 Methionyl tRNA synthetase polynucleotides
04/22/2008US7361475 Compositions and methods relating to colon specific genes and proteins
04/22/2008US7361474 Serum macrophage migration inhibitory factor (MIF) as marker for prostate cancer
04/22/2008US7361473 Evaluation of acute coronary syndromes patient test samples are analyzed for the presence and amount of test samples are analyzed for the presence and amount of members of a panel of markers comprising one or more specific markers for
04/22/2008US7361472 Detection of preferential particles in sample: obtain sample, expose sample to light, monitor sample response to light
04/22/2008US7361471 Nucleic acid archiving
04/22/2008US7361467 Incubating with a nucleic acid polymerase to form duplex and single-stranded nucleic acid; cleaving with FEN(5'flap-specific) nuclease to generate a signal
04/22/2008US7361466 Nucleic acid analysis using terminal-phosphate-labeled nucleotides
04/22/2008US7361464 Method, systems and kits for immuno-detection of epitopes expressed on molecules
04/22/2008US7361463 Degradation resistant antihypoxic agents for use in treatment and prevention of hypoxia and ischemic related tissue damage
04/22/2008US7361462 Identifying disruption in nucleotide sequence fragment using DNA repair protein and immunoglobulin binding; immunoassay
04/22/2008US7361460 Approach to molecular diagnosis of human papillomavirus-related diseases
04/22/2008US7361459 Antiviral inhibition of capsid proteins
04/22/2008US7361356 Gene expression in host cell of conformational epitopes; used as elements of diagnostic immunoassay procedures for papillomavirus infection
04/22/2008US7361354 Methods for treating malignancies expressing ICAM-1 using coxsackie a group viruses
04/22/2008US7361353 Genomic sequence that encode ptorprotein; drug for prevention, therapy of infections; induce immunology response
04/22/2008US7361351 Therapeutic uses of rbosCD14 both as an inhibitor of activation which occurs in an acute inflammatory response and as a sensitizer of bovine mammary ductal epithelial cells resulting in leukocyte recruitment and initiation of immune response
04/22/2008US7361348 Immunogenic glycopeptides, screening, preparation and uses
04/22/2008US7361345 monoclonal antibody prevents the growth or differentiation of the B cell; secreted by the hybridoma; therapy of autoimmune diseases, sytematic lupus erythematosus, primary biliary cirrhosis, and idiopathic thrombocytopenic purpura; biodrug
04/22/2008US7361343 Customization of cancer therapy by adminstering modifying antibodies from antigens expressed from cancerous tissue which are cytotoxic to cancer cells while non-toxic to non-cancerous cells; monoclonal antibody antigen binding fragment having identifying characteristics to deposit PTA-4890 at the ATCC
04/22/2008US7361342 Cancerous disease modifying antibodies
04/22/2008US7361341 Methods of treating cancer using antibodies that immunospecifically bind to trail receptors
04/22/2008US7361340 Specifically recognizing human oculospanin and having cytotoxic activity against cancer cells, cancer therapy
04/22/2008US7361337 Antibodies against the PRO1754 polypeptides
04/22/2008US7361336 Administering antibody or a fragment thereof that binds to a human homolog of frizzled, to inhibit the proliferation of cancer cells
04/22/2008US7361308 For transferring the plugs to microtitre plates/test tubes for further analysis; comprises a needle
04/22/2008US7361307 Micro-piercing member used to penetrate the skin to a selected depth and to access biological fluid, a constituent sampling means and a constituent measuring means
04/22/2008US7361306 Device and method for measuring coagulation time and platelet activity
04/22/2008US7361133 Methods of detection utilizing modified bacteriophage
04/22/2008US7360844 Geosteering detectors for boring-type continuous miners
04/22/2008US7360444 Interaction device for a mold for a gyratory compactor
04/22/2008US7360402 Water quality detecting device for an aquarium
04/22/2008CA2490436C Hand-held analytical device
04/22/2008CA2449227C Tissue biopsy and processing device
04/22/2008CA2446572C Method for screening microcrystallizations for crystal formation
04/22/2008CA2394746C Chromatography material and a method using same
04/22/2008CA2302448C Low volume electrochemical sensor
04/22/2008CA2297694C Antibodies and diagnostic methods for the diagnosis of pestviruses
04/22/2008CA2151118C Device for carrying out urease tests for combined antrum/corpus biopsies to diagnose gastro-intestinal illnesses
04/17/2008WO2008045767A2 Detection of gadolinium chelates
04/17/2008WO2008045565A1 Biodiesel/diesel blend level detection using absorbance
04/17/2008WO2008045344A2 Methods to determine responsiveness to cisplatin treatment
04/17/2008WO2008045323A2 Method for determination of dht levels in tissue samples
04/17/2008WO2008045307A2 Emissive compositions with internal standard and related techniques
04/17/2008WO2008045136A2 Nucleic acid size detection method
04/17/2008WO2008045115A2 Method for localizing labels in a sample
04/17/2008WO2008044957A1 Proteom differential analysis method
04/17/2008WO2008044797A1 Osteopenia model animal
04/17/2008WO2008044787A1 Composition for treating cancer using dref as molecular target
04/17/2008WO2008044779A1 Micro-pixelated fluid-assay structure, micro-pixelated fluid-assay precursor structure, and making method and performing method thereof
04/17/2008WO2008044748A1 Micro-pixelated fluid-assay structure and making method of the same
04/17/2008WO2008044660A1 Screening method for prokinetic agent
04/17/2008WO2008044599A1 Polypeptide having activity of targeting intestine having inflammation, and use thereof
04/17/2008WO2008044379A1 Bone loss model animal
04/17/2008WO2008044351A1 Novel transporter protein in mammal, and use thereof
04/17/2008WO2008044311A1 Method for identifying abnormal state, analytical apparatus, and reagent
04/17/2008WO2008044214A1 Fast biosensor with reagent layer
04/17/2008WO2008044186A2 Environmental state detection with hydrogel based fully integrated transducer device
04/17/2008WO2008044179A1 Biosensors and preparation thereof
04/17/2008WO2008044174A1 Magnetic and/or electric label assisted detection system and method
04/17/2008WO2008044138A1 Optical nanosensor for detection of reactive oxygen species
04/17/2008WO2008044076A2 Therapy targeting cathepsin s
04/17/2008WO2008044043A1 Method and detection device for nitric oxide and its metabolites
04/17/2008WO2008044038A2 Conjugates for use in analite detection
04/17/2008WO2008044028A2 Labelling groups
04/17/2008WO2008043963A1 Cell coloration method
04/17/2008WO2008043952A2 System for determining the mass flow rate of nitrogen oxides emitted in the exhaust gases of an internal combustion engine
04/17/2008WO2008043894A1 Chalcogenide glass and chemical sensor comprising the same
04/17/2008WO2008043851A1 A non-homogeneous quencher free assay method for the noradrenaline transporter